Sort

Search

01/08/2025 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
de Lazzari, E, Di Gregorio, S, Rojas, J, Curran, A, Domingo, P, Negredo, E, Tiraboschi, J, Gonzalez-Cordon, A, Torres, B, Sempere, A, Inciarte, A, Gatell, JM, Blanco, JL, Martinez, E. 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(8)DOI:10.1093/jac/dkaf192. PMID:40556520. IF:3.600(Q2/3D).
01/08/2025 A randomized study of 2 risk assessment models for individualized breast cancer risk estimation
López-Fernández, A, Duran-Lozano, L, Villacampa, G, Pardo, M, Pérez, E, Darder, E, Vallmajó, A, Alfonso, R, Cruellas, M, Roqué, A, Cartró, M, Bareas, A, Carrasco, E, Rezqallah, A, Jimenez-Macedo, AR, Torres-Esquius, S, Torres, M, Lopez, C, Espinosa, M, Teulé, A, Munté, E, Tuset, N, Diez, O, Feliubadaló, L, Lázaro, C, Llort, G, Carver, T, Ficorella, L, Mavaddat, N, Mercadé, A, Antoniou, AC, Brunet, J, Cajal, TRY, Balmaña, J. A randomized study of 2 risk assessment models for individualized breast cancer risk estimation. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; 117(8)DOI:10.1093/jnci/djaf067. PMID:40170233. IF:7.200(Q1/2D).
01/08/2025 Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
van der Heijden, MS, Powles, T, Gupta, S, Loriot, Y, Galsky, MD, Valderrama, BP, Sridhar, SS, Yu, EY, Iyer, G, Kikuchi, E, Castellano, D, Hoffman-Censits, J, Drakaki, A, Mar, N, Rey, JPM, Vulsteke, C, Arafat, W, Duran, I, Dawson, NA, Swami, U, Gorla, S, Moreno, BH, Yu, X, Lu, YT, Bedke, J. Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma. ESMO Open. 2025; 10(8)DOI:10.1016/j.esmoop.2025.105544. PMID:40795788. IF:8.300(Q1/2D).
01/08/2025 Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach
Chaachou-Charradi, A, Bagué, S, Medina, CM, Lavernia, J, Claramunt, R, Guerrero, JAL, Navarro, S, Llombart-Bosch, A, Williamson, SR, Machado, I. Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2025; 33(5)DOI:10.1177/10668969241308205. PMID:39865727. IF:1.000(Q3/8D).
01/08/2025 To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy
Pinana, JL, Martino, R, Cesaro, S, Averbuch, D, Lujgman, P. To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy. CURRENT OPINION IN INFECTIOUS DISEASES. 2025; 38(4)DOI:10.1097/QCO.0000000000001120. PMID:40471062. IF:4.000(Q1/2D).
01/08/2025 A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Camps-Renom, P, Guasch-Jiménez, M, Martinez-Domeño, A, Prats-Sánchez, L, Ramos-Pachón, A, Alvarez-Cienfuegos, J, Silva, Y, Fortea-Cabo, G, Morales-Caba, L, Rodríguez-Campello, A, Giralt-Steinhauer, E, Flores, A, Ustrell, X, López-Hernández, N, Corona-García, DJ, Freijo-Guerrero, MM, Luna, A, Tejada-Meza, H, Marta-Moreno, J, Moniche, F, Pardo-Galiana, B, Castellanos, M, Albert-Lacal, L, Sanz-Monllor, A, Aguilera-Simón, A, Marín, R, Ezcurra-Díaz, G, Lambea-Gil, A, Marti-Fàbregas, J. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). CEREBROVASCULAR DISEASES. 2025; 54(4)DOI:10.1159/000540606. PMID:39208776. IF:1.500(Q3/8D).
01/08/2025 Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study
García-Alfonso, P, Jimenez-Fonseca, P, Soto-Alsar, J, Baraibar, I, Santos, C, La Casta, A, Ghanem, I, Cortijo, G, Méndez, A, Pazo-Cid, R, Vera, R, Melián, M, Alcaide, J, Graña, B, Páez, D, Gallego, I, Lobo, M, Borregón, M, Montes, A, de Castro, E, Carmona-Bayonas, A, Aranda, E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. ONCOLOGIST. 2025; 30(8)DOI:10.1093/oncolo/oyae300. PMID:39550209. IF:4.200(Q2/3D).
01/08/2025 Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome
Sánchez-Moreno, B, Zhang, LD, Salaberry, AC, Rozalem-Aranha, M, Moldenhauer, F, Brudfors, M, Ashburner, J, Nachev, P, de Asúa, DR, Strange, BA. Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(8)DOI:10.1002/alz.70296. PMID:40762120. IF:11.100(Q1/1D).
01/08/2025 Older adults and low-severity emergencies: oversue of hospital emergency services?
Puig-Campmany, M, Ris-Romeu, J. Older adults and low-severity emergencies: oversue of hospital emergency services?. EMERGENCIAS. 2025; 37(4)DOI:10.55633/s3me/065.2025. PMID:40887909. IF:6.300(Q1/1D).
01/08/2025 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old: a Cochrane review
Roqué-Figuls, M, Giné-Garriga, M, Rugles, CG, Perrotta, C, Vilaró, J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old: a Cochrane review. EMERGENCIAS. 2025; 37(4)DOI:10.55633/s3me/060.2025. PMID:. IF:6.300(Q1/1D).
01/08/2025 Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure
Espinosa, B, Llauger, L, Gil, V, Escoda, R, Jacob, J, Aguirre, A, Mojarro, EM, Tost, J, Alquézar-Arbé, A, López-Grima, ML, Millán, J, Massó, M, Cuquerella, GS, Pagán, F, Núñez, J, Dauw, J, Müllens, W, Llorens, P, Miró, O. Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure. Internal and Emergency Medicine. 2025; 20(5)DOI:10.1007/s11739-024-03796-0. PMID:39472392. IF:3.800(Q1/2D).
01/08/2025 Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study
Blanco-Carrasco, AJ, Merino-Torres, JF, Almanza, MR, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, de Isla, LP, González, JFN. Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112214. PMID:40319920. IF:7.400(Q1/1D).
01/08/2025 Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy
Meek, CL, Feig, DS, Scott, EM, Corcoy, R, Murphy, HR. Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy. DIABETES CARE. 2025; 48(8)DOI:10.2337/dc24-2494. PMID:40173096. IF:16.600(Q1/1D).
01/08/2025 Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy
Schiava, M, Parkhurst, Y, Henderson, M, Polvikoski, T, Valtcheva, MV, Nishino, I, Inoue, M, Nishimori, Y, Saito, Y, Stojkovic, T, Villar-Quiles, RN, Romero, NB, Evangelista, T, Malfatti, E, Souvannanorath, S, Pegoraro, E, Riguzzi, P, Monforte, M, Bortolani, S, Torchia, E, Sabatelli, M, Tasca, G, Straub, V, Marini-Bettolo, C, Guglieri, M, Cetin, H, Gelpi, E, Klotz, S, De Bleecker, JL, Alonso-Jimenez, A, Baets, J, De Ridder, W, De Jonghe, P, Claeys, KG, Thal, DR, Bevilacqua, JA, Luo, SS, Zhu, WH, Lin, J, Papadimas, G, Papadopoulos, C, Zamba-Papanicolaou, E, Xirou, S, Pal, E, Rodolico, C, Kostera-Pruszczyk, A, Kierdaszuk, B, Kaminska, A, Muelas, N, Vilchez, JJ, Domínguez-González, C, Hernandez-Lain, A, Alonso-Perez, J, Nedkova-Hristova, V, Aledo, C, Oldfors, A, Badrising, UA, Kushlaf, H, Lloyd, TE, Ikenaga, C, Alfano, LN, Quinn, CC, Walk, D, Vorgerd, M, Weihl, C, Olivé, M, Diaz-Manera, J. Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy. Neurology-Genetics. 2025; 11(4)DOI:10.1212/NXG.0000000000200265. PMID:40678441. IF:3.700(Q1/3D).
01/08/2025 Secretome from recently symptomatic carotid plaques present higher content of inflammatory and antioxidant molecules compared to asymptomatic plaques
Puig, N, Camps-Renom, P, Pérez, B, Aguilera-Simón, A, Solé, A, Camacho, M, Jiménez-Altayó, F, Sanchez-Quesada, JL, Benitez, S. Secretome from recently symptomatic carotid plaques present higher content of inflammatory and antioxidant molecules compared to asymptomatic plaques. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025 High-grade glioma: combined use of 5-aminolevulinic acid and intraoperative ultrasound for resection and a predictor algorithm for detection
Aibar-Durán, JA, Mirapeix, RM, Alcañiz, AG, Salgado-López, L, Freixer-Palau, B, Hernando, VC, Hernández, FM, de Quintana-Schmidt, C. High-grade glioma: combined use of 5-aminolevulinic acid and intraoperative ultrasound for resection and a predictor algorithm for detection. JOURNAL OF NEUROSURGERY. 2025; 143(2)DOI:10.3171/2024.12.JNS242496. PMID:40250048. IF:3.600(Q1/2D).
01/08/2025 Hemodynamic support Prospective multicenter observational study of patients in shock treated with vasopressin: Protocol of the VASOPRESIN with vasopressin: VASOPRES Registry study protocol
Alvarez, RG, Ramasco, F, Alonso, JN, Mouriz, L, Rama, P, Bilbao, I, Carbonell, AP, Rodenas, MA, Ortega, F, Vives, M, Calvo, CA, Taboada, M, Azzam, A, Merino, M, Martinez, F, Dominguez, D, de Llano, CT, Adalia, R, Aguilar, G, Aldecoa, C, Mancha, B, Reyes, A, Giné, M, Prendes, D, Fernández, CG, de la Calle, I, Cendrero, M, López, AM, Herrero, JJ, de la Torre, I, Kattan, E, Hernández, G. Hemodynamic support Prospective multicenter observational study of patients in shock treated with vasopressin: Protocol of the VASOPRESIN with vasopressin: VASOPRES Registry study protocol. Revista Espanola De Anestesiologia Y Reanimacion. 2025; 72(7)DOI:10.1016/j.redar.2025.501768. PMID:. IF:(Q/D).
31/07/2025 A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor
Mohapatra, AK, Vlieg, AV, Kleber, ME, Martinez-Perez, A, Le, NQ, Hindberg, KD, Dusart, P, Germain, M, Thibord, F, Deleuze, JF, Delgado, GE, Goumidi, L, Suchon, P, Saut, N, Souto, JC, Butler, LM, Soria, JM, Hansen, JB, März, W, Rosendaal, FR, Castoldi, E, Peiretti, F, Sabater-Lleal, M, Trégouët, DA, Morange, PE. A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor. BLOOD. 2025; 146(5)DOI:10.1182/blood.2024027006. PMID:40359434. IF:23.100(Q1/1D).
31/07/2025 Unveiling the Spectrum: Clinical and Molecular Insights from a Spanish Pediatric Cohort with Hypermobility Disorders and Ehlers-Danlos Syndrome
Felipe, DF, Casas-Alba, D, Sadok, SH, Fernández, MT, Vega-Hanna, L, Plaza, L, Villa, AV, Armstrong, J, Guillén-Navarro, E, Martínez-Monseny, AF. Unveiling the Spectrum: Clinical and Molecular Insights from a Spanish Pediatric Cohort with Hypermobility Disorders and Ehlers-Danlos Syndrome. Genes. 2025; 16(8)DOI:10.3390/genes16080925. PMID:40869974. IF:2.800(Q2/5D).
25/07/2025 Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach
Zapatero, A, Alonso-Gordoa, T, Antolín, AR, Couñago, F, Sanmamed, N, Esteban, MD, Valcárcel, ML, Manneh, R, Borque-Fernando, A, González, NS, Maroto, P. Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach. Oncology Reviews. 2025; 19DOI:10.3389/or.2025.1599292. PMID:40787089. IF:(Q/D).